March 2018

Along with other companies, 5AM Ventures (which Scott M. Rocklage is a founding and managing partner of), has been helping finance Expansion Therapeutics’ Series A financing for fighting genetic disorders, such as myotonic dystrophy type 1, the leading cause of muscular dystrophy in adults. Expansion Therapeutics focuses on creating medications that intervene in illnesses that
Read More